In the Works...
In collaboration with our partner Bills Biotech, we are in the process of obtaining Market Launching Authorization for a topical antibiotic based on mupirocin and an immunosuppressive medicine based on tacrolimus. Both mupirocin and tacrolimus are produced by Bills Biotech through a unique state of the art bacterial fermentation process.
Stay tuned for more details and when the products will be available.
![Bactecidin_banner6](https://safibio.com/wp-content/uploads/2023/03/Bactecidin_banner6.png)
![Bactecidin_banner5](https://safibio.com/wp-content/uploads/2023/03/Bactecidin_banner5.png)
![Bactecidin_Graften_banner1](https://safibio.com/wp-content/uploads/2023/03/Bactecidin_Graften_banner1.png)
![Bactecidin_banner1](https://safibio.com/wp-content/uploads/2023/03/Bactecidin_banner1.png)
![Health_banner7](https://safibio.com/wp-content/uploads/2023/03/Health_banner7.png)